SOD1 and amyotrophic lateral sclerosis: The potential for its use was tested by Raoul et al. By bilateral spinal injection of VSV-G LV causing SOD1 silencing mediated by RNA interference, in SOD1-G93A transgenic mice of the family ALS (fALS) model, they achieved a delay in disease onset and progression [96].